Preoperative evaluation and oncologic principles of colon cancer surgery

Clinics in Colon and Rectal Surgery

Volumn 18, Issue 3, 2005, Pages 163-173

  Lynch, Matthew L ^a   Brand, Marc I ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Colectomy; Colon cancer; Screening

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CLINDAMYCIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METRONIDAZOLE; PENICILLIN DERIVATIVE;

AGING; ALCOHOL CONSUMPTION; AMBULATORY CARE; ANASTOMOSIS; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; BLOOD CELL COUNT; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLON CANCER; COLON RESECTION; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DEVICE; DIETARY FIBER; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; INTESTINE PREPARATION; LAPAROSCOPIC SURGERY; LIPID DIET; LYMPHATIC DRAINAGE; METASTASIS; OBESITY; PREOPERATIVE EVALUATION; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SMOKING; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; THROMBOSIS PREVENTION;

EID: 24344459869     PISSN: 15310043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916277     Document Type: Review

References (48)

1. American Cancer Society. Cancer Facts and Figures 2003. Available at http://www.cancer.org/docroot/STT/stt_0_2003. asp?sitearea=STT&level=l. Accessed December 6, 2004
2. American Cancer Society. Cancer Statistics 2004. Available at http://www.cancer.org/docroot/STT/stt_0.asp. Accessed December 7, 2004
3. Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E. Familial aggregation of colorectal cancer in the general population. Int J Cancer 1996;68:428-435
4. Samowitz WS, Curtin K, Lin HH, et al. The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 2001;121:830-838
5. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998; 338:1481-1487
6. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991;34:424-425
7. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110: 1020-1027
8. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-535
9. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994;35:1590-1592
10. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-1425
11. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fecal-occult-blood test. Lancet 1996;348:1467-1471
12. Church TR, Ederer F, Mandel JS. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst 1997;89:1440-1448
13. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 1997;126:811-822
14. Trowbridge B, Burt RW. Colorectal cancer screening. Surg Clin North Am 2002;82:943-957
15. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-951
16. U.S. Preventive Services Task Force, Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-131
17. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol 2000;95:868-877
18. Eaden JA, Mayberry JF. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002;51:V10-V12
19. Anonymous (ASCO Subcommittee on genetic testing for cancer susceptibility). Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J Clin Oncol 1996;14:1730-1736
20. Giardiello FM. Genetic testing in hereditary colorectal cancer. JAMA 1997;278:1278-1281
21. Burke W, Petersen G, Lynch P, et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997;277:915-919
22. Harrison LE, Guillem JG, Paty P, Cohen AM. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997;185:55-59
23. Neri E, Giusti P, Battolla L, et al. Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy. Radiology 2002;223:615-619
24. McAndrew MR, Saba AK. Efficacy of routine computed tomography scans in colon cancer. Am Surg 1999;65:205-208
25. Barton JB, Langdale LA, Cummins JS, et al. The utility of routine computed tomography scanning in the management of veterans with colon cancer. Am J Surg 2002;183:499-503
26. Chung HW, Chung JB, Park SW, Song SY, Kang JK, Park CI. Comparison of hydrocolonic sonography accuracy in preoperative staging between colon and rectal cancer. World J Gastroenterol 2004;10:1157-1161
27. Oliveira L, Wexner SD, Daniel N, et al. Mechanical bowel preparation for elective colorectal surgery. A prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions. Dis Colon Rectum 1997;40:585-591
28. Slim K, Vicaut E, Panis Y, Chipponi J. Meta-analysis of randomized clinical trials of colorectal surgery with or without mechanical bowel preparation. Br J Surg 2004;91:1125-1130
29. Nichols RL, Smith JW, Garcia RY, Waterman RS, Holmes JW. Current practices of preoperative bowel preparation among North American colorectal surgeons. Clin Infect Dis 1997;24:609-619
30. McLeod RS, Geerts WH, Sniderman KW, et al. Subcutaneous heparin versus low-molecular-weight heparin as thrombbprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 2001;233:438-444
31. Palmer AJ, Schramm W, Kirchhof B, Bergemann R. Low molecular weight heparin and unfractionated heparin for prevention of thrombo-embolism in general surgery, a meta-analysis of randomised clinical trials. Haemostasis 1997;27: 65-74
32. Kercher KW, Nguyen TH, Harold KL, et al. Plastic wound protectors do not affect wound infection rates following laparoscopic-assisted colectomy. Surg Endosc 2004;18:148-151
33. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001;93: 583-596
34. Chen HS, Sheen-Chen SM. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery 2000;127:370-376
35. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg 1988;75:409-415
36. Phillips EH, Franklin M, Carroll BJ, Fallas MJ, Ramos R, Rosenthal D. Laparoscopic colectomy. Ann Surg 1992;216: 703-707
37. Berends FJ, Kazemier G, Bonjer HJ, Lange JF. Subcutaneous metastases after laparoscopic colectomy. Lancet 1994;344:58
38. The Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350:2050-2059
39. Feliciotti F, Paganini AM, Guerrieri M, De Sanctis A, Campagnacci R, Lezoche E. Results of laparoscopic vs open resections for colon cancer in patients with a minimum follow-up of 3 years. Surg Endosc 2002;16:1158-1161
40. Abraham NS, Young JM, Solomon MJ. Meta-analysis of short-term outcomes after laparoscopic resection for colorectal cancer. Br J Surg 2004;91:1111-1124
41. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999;17:2896-2900
42. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29
43. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004;240:624-630
44. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, McCall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001;44:410-417
45. Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001;44:850-856
46. Benson AB, Desch CE, Flynn PJ, et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000;18:3586-3588
47. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998;228:59-63
48. Anthony T, Simmang C, Hyman N, et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004;47:807-817